Literature DB >> 11359076

Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study.

M W Knuiman1, A R Folsom, L E Chambless, D Liao, K K Wu.   

Abstract

OBJECTIVES: Population-based and clinical prospective studies have shown independent associations of several hemostatic factors with ischemic heart disease and stroke. MRI-detected cerebral infarcts and white matter lesions are often detected in elderly individuals without clinical disease. It has been hypothesized that these types of lesions are often the consequence of cerebral ischemic damage and may be the precursors of clinical stroke.
METHODS: This study examined the relation between a range of hemostatic factors measured at baseline in middle-aged participants who were free of diagnosed cardiovascular disease in the Atherosclerosis Risk in Communities Study and MRI-detected cerebral abnormalities at a 6-year follow-up examination.
RESULTS: Plasma fibrinogen and perhaps von Willebrand factor were associated positively, and protein C was associated negatively, with cerebral infarctions. Adjusted for other risk factors, the odds ratio for cerebral infarction was 1.21 (95% confidence interval, CI = 1.02-1.44) per standard deviation increment for fibrinogen, 1.15 (95% CI = 0.97-1.37) per standard deviation increment for von Willebrand factor, and 0.77 (95% CI = 0.62-0.95) per standard deviation increment for protein C. No hemostatic factor, however, was associated with white matter disease.
CONCLUSIONS: This study has only a follow-up MRI, and it is likely that some MRI lesions were present at baseline. Nevertheless, increased levels of fibrinogen and von Willebrand factor and reduced levels of protein C appear to be associated with cerebral infarction identified by MRI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359076     DOI: 10.1159/000054767

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

1.  Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  James S Pankow; Weihong Tang; Nathan Pankratz; Weihua Guan; Lu-Chen Weng; Mary Cushman; Eric Boerwinkle; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-12       Impact factor: 8.311

2.  Vascular and cognitive functions associated with cardiovascular disease in the elderly.

Authors:  Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-16       Impact factor: 2.475

Review 3.  Hypercoagulable states and strokes.

Authors:  Nena Matijevic; Kenneth K Wu
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

4.  Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study.

Authors:  R F Gottesman; C Cummiskey; L Chambless; K K Wu; N Aleksic; A R Folsom; A R Sharrett
Journal:  Cerebrovasc Dis       Date:  2009-10-16       Impact factor: 2.762

5.  A histopathological analysis of the epidemiology of coronary atherosclerosis: an autopsy study.

Authors:  Negin Abedinzadeh; Behnam Pedram; Yasan Sadeghian; Seyed Mohamad Hossein Tabatabaei Nodushan; Maryam Gilasgar; Mahsa Darvish; Aram Mokarizadeh
Journal:  Diagn Pathol       Date:  2015-07-03       Impact factor: 2.644

6.  Association between Circulating Protein C Levels and Incident Dementia: The Atherosclerosis Risk in Communities Study.

Authors:  Adrienne Tin; Keenan A Walker; Jan Bressler; B Gwen Windham; Michael Griswold; Kevin Sullivan; Aozhou Wu; Rebecca Gottesman; Myriam Fornage; Josef Coresh; A Richey Sharrett; Aaron R Folsom; Thomas H Mosley
Journal:  Neuroepidemiology       Date:  2021-06-02       Impact factor: 5.393

Review 7.  The epidemiology of silent brain infarction: a systematic review of population-based cohorts.

Authors:  Jonathon P Fanning; Andrew A Wong; John F Fraser
Journal:  BMC Med       Date:  2014-07-09       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.